
Read our key takeaways from the 2022 ASAS-EULAR recommendations for the management of axSpA, presented as part of Dr Sofia Ramiro's workshop at UCB Summit 2023.
Professor Lars Erik Kristensen is Head of Research at the Parker Institute in Copenhagen, Denmark, and holds an honorary doctoral position at Lund University, Sweden, and a professorship at Copenhagen University, Denmark. He received his medical degree from Copenhagen University and a PhD in Clinical Medicine from Lund University. He later specialised in internal medicine and rheumatology. Professor Kristensen also completed a postdoc at Karolinska University, Sweden.
Professor Kristensen’s research interests are degenerative and inflammatory arthritis, with a focus on patient value, lifestyle factors, treatment response and predictors thereof in randomised controlled trials and observational settings. He also managed his own research group (South Swedish Arthritis Treatment Group [SSATG]) in Lund from 2011 to 2013. Professor Kristensen is also a board member and head of research at the Danish Society of Rheumatology. He has given >250 lectures at national and international congresses and meetings.
Watch Prof Robert Landewé discuss the importance of using ASDAS <2.1 as a treatment target for patients with axSpA.
Read our key takeaways from the 2022 ASAS-EULAR recommendations for the management of axSpA, presented as part of Dr Sofia Ramiro's workshop at UCB Summit 2023.
Watch Prof Lars Erik Kristensen and Prof Frank Behrens discuss the role of the IL-17 family of cytokines in SpA pathobiology.
Join Prof Dennis McGonagle and Prof Lars Erik Kristensen in unraveling the role of the IL-17 family in the pathogenic inflammation and manifestations of SpA in...
Play the animation to accompany Assoc. Prof Philipp Sewerin in deciphering the role of extracellular cytokine targets in SpA pathobiology.
In this session, the speakers highlight the importance of family planning conversations with women of childbearing age, so that appropriate treatment plans can...